MedPath

Comparing MTA Pulpotomy to Root Canal Treatment in Management of Permanent Molars With Irreversible Pulpitis in Children

Phase 4
Not yet recruiting
Conditions
Irreversible Pulpitis
Interventions
Procedure: MTA Pulpotomy
Procedure: Root Canal Treatment
Registration Number
NCT06488131
Lead Sponsor
Ain Shams University
Brief Summary

Dental caries, highly prevalent amongst children, can cause pulpitis. Coronal pulpotomy provides an easier, cost-effective, conservative and biologically-driven treatment option compared to endodontic treatment in mature permanent teeth with irreversible pulpitis.

The aim of the current study is to evaluate postoperative pain, clinical and radiographic outcomes of MTA pulpotomy compared to root canal treatment in children's first permanent molars suffering from irreversible pulpitis.

Detailed Description

In this randomized controlled trial, patients aged 10-14 years suffering from irreversible pulpitis in the first permanent molar with closed apex will be randomly divided into two groups. The first group will receive complete coronal MTA pulpotomy, while the second group will receive endodontic treatment.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Healthy male and female children, aged 10 to 14 years
  • Signs and symptoms of irreversible pulpitis in carious first permanent molar.
Exclusion Criteria
  • Molars with immature roots
  • Non-restorable molars, with abnormal mobility or increased probing pocket depth (normal range = 1-3 mm)
  • Any indication of pulpal necrosis, such as sinus tract or swelling or no bleeding from orifices after access opening.
  • Any signs of periapical or furcal rarefaction.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MTA PulpotomyMTA PulpotomyLocal anesthesia for pain control will be administered, followed by rubber dam isolation. Then, the tooth and surrounding rubber dam will be flushed with chlorhexidine solution for disinfection. After caries removal, a sterile bur will be used for access opening and complete deroofing of the pulp chamber. Coronal pulp tissue will be removed to the level of canal orifices using a sterile, sharp spoon excavator. A cotton pellet dampened with sodium hypochlorite will be applied on canal orifices to achieve hemostasis. This will be followed by MTA application and glass ionomer restoration. If necessary, the tooth will be restored with stainless steel crown after one week.
Root Canal TreatmentRoot Canal TreatmentLocal anesthesia for pain control will be administered, followed by rubber dam isolation. Then, the tooth and surrounding rubber dam will be flushed with chlorhexidine solution for disinfection. After caries removal, a sterile bur will be used for access opening and complete deroofing of the pulp chamber. Length of the root canal will be obtained using an apex locator. This will be followed by mechanical shaping using files, and irrigation with 2.5 percent sodium hypochlorite, followed by drying of the canals using paper points. Obturation will then be accomplished using gutta percha and sealer. Finally, the tooth will be restored with conventional glass ionomer restoration. If necessary, the tooth will be restored with stainless steel crown after one week.
Primary Outcome Measures
NameTimeMethod
Pain Reliefpreoperatively, immediately postoperatively and every 24 hours for 7 days after the first appointment.

A 10 cm visual analogue scale will be used to record pain

Secondary Outcome Measures
NameTimeMethod
Radiographic Evaluation6, 12 and 18 months postoperatively

* No evident radiographic periapical or furcal pathosis

* No evident root resorption

* Normal lamina dura

Clinical Evaluation3, 6, 12 and 18 months postoperatively

* Absence of pain or discomfort

* Tooth is functional, with no tenderness to palpation or percussion

* Normal mobility and probing depth

* Soft tissues surrounding the tooth are normal, with no swelling or inflammation

© Copyright 2025. All Rights Reserved by MedPath